SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-22-006469
Filing Date
2022-01-21
Accepted
2022-01-21 16:15:52
Documents
1
Group Members
5AM OPPORTUNITIES I (GP), LLC5AM OPPORTUNITIES I, L.P.5AM VENTURES VI, LLCANDREW J. SCHWABDR. KUSH PARMAR

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tm223316d1_sc13g.htm SC 13G 119985
  Complete submission text file 0001104659-22-006469.txt   121635
Mailing Address 501 SECOND STREET, SUITE 350 SAN FRANCISCO CA 94107
Business Address 501 SECOND STREET, SUITE 350 SAN FRANCISCO CA 94107 415-993-8570
5AM Ventures VI, L.P. (Filed by) CIK: 0001753037 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116 8445311834
CinCor Pharma, Inc. (Subject) CIK: 0001868734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93228 | Film No.: 22546106
SIC: 2834 Pharmaceutical Preparations